SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: (Original Filing)
[]
SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: (Original Filing)
[Item 5.07 Submission of Matters to a Vote of Security Holders On October 25, 2012, at 7:45 pm (PRC time),ystar Bio-Pharmaceuticalmpany (thempany) held its Annual Meeting of Shareholders at thempanys executive officers in Xian, Shaanxi Province, China. Set forth below are the matters voted upon at the meeting and the voting results:]
SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: Item 5.07 Submission of Matters to a Vote
[Item 5.07 Submission of Matters to a Vote of Security Holders On October 25, 2012, at 7:45 pm (PRC time),ystar Bio-Pharmaceuticalmpany (thempany) held its Annual Meeting of Shareholders at thempanys executive officers in Xian, Shaanxi Province, China. Set forth below are the matters voted upon at the meeting and the voting results:]
BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)
[FORM 8-K CURRENT REPORTte of Report (Date of earliest event reported):October 26, 2012 ______________ BIOSTAR PHARMACEUTICALS, ______________ Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer oforporation) Identification No.) No. 588 Shiji Xi Avenue Xianyang City, Shaanxi Province, Peoples Republic of China 712046 86-029-33686638 N/A (Former name or formerdress, if changed since last report)]
BSPM [Biostar Pharmaceuticals,] 8-K: FORM 8-K CURRENT REPORTte of Report (Date of
[FORM 8-K CURRENT REPORTte of Report (Date of earliest event reported):October 26, 2012 ______________ BIOSTAR PHARMACEUTICALS, ______________ Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer oforporation) Identification No.) No. 588 Shiji Xi Avenue Xianyang City, Shaanxi Province, Peoples Republic of China 712046 86-029-33686638 N/A (Former name or formerdress, if changed since last report)]
TPI [TIANYIN PHARMACEUTICAL] CORRESP: (Original Filing)
[October 23, 2012 Division of Corporate Finance 100 F. Street, N.E. Attn: Nandini Acharya Re: Tianyin Pharmaceutical Co., Inc. Dear Ms. Acharya: This letter is provided in response to your letters dated April 5, 2012 and June 27, 2012, regarding the above-referenced Post Effective Amendments to Form S-1 for Tianyin Pharmaceutical Co., Inc. (the “Company”). Responses are set forth below]
TPI [TIANYIN PHARMACEUTICAL] CORRESP: October 23, 2012 Division of Corporate Finance 100
[October 23, 2012 Division of Corporate Finance 100 F. Street, N.E. Attn: Nandini Acharya Re: Tianyin Pharmaceutical Co., Inc. Dear Ms. Acharya: This letter is provided in response to your letters dated April 5, 2012 and June 27, 2012, regarding the above-referenced Post Effective Amendments to Form S-1 for Tianyin Pharmaceutical Co., Inc. (the “Company”). Responses are set forth below]
TPI [TIANYIN PHARMACEUTICAL] POS AM: (Original Filing)
[Post Effective Amendment No.3 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Tianyin Pharmaceutical Co., Inc. Delaware (State or other jurisdiction of incorporation or organization) 20-4857782 (I.R.S. Employer Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 Renmin Road South, Chengdu, P. R. China, 610041 +0086-28-86154737 Dr. Guoqing Jiang Chief Executive Officer Tianyin Pharmaceutical Co.,] [HUNTER TAUBMAN WEISS LLP 17 State Street, Suite 2000 New York, New York 10007 (212) 732-7184 Fax: (212) 202-6380 E-mail: LTaubman@htwlaw.com October 23, 2012 Tianyin Pharmaceutical Co., Inc. 23rd Floor, Unionsun Yangkuo Plaza No. 2, Block 3, Renmin Road South Chengdu, P. R. China, 610041 Ladies and Gentlemen: In so acting, we have examined and relied upon the originals or] [Patrizio & Zhao, LLC Certified Public Accountants and Consultants 322 Route 46 West Parsippany, NJ 07054 Fax: (973) 882-0788 www.pzcpa.com Member of Alliance of worldwide accounting firms CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the use in the Post-Effective Amendment No. 3 to a Registration Statement on Form S-1 pertaining to the registration of 15,784,640 shares of]
TPI [TIANYIN PHARMACEUTICAL] POS AM: Post Effective Amendment No.3 to FORM S-1 REGISTRATION
[Post Effective Amendment No.3 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Tianyin Pharmaceutical Co., Inc. Delaware (State or other jurisdiction of incorporation or organization) 20-4857782 (I.R.S. Employer Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 Renmin Road South, Chengdu, P. R. China, 610041 +0086-28-86154737 Dr. Guoqing Jiang Chief Executive Officer Tianyin Pharmaceutical Co.,] [HUNTER TAUBMAN WEISS LLP 17 State Street, Suite 2000 New York, New York 10007 (212) 732-7184 Fax: (212) 202-6380 E-mail: LTaubman@htwlaw.com October 23, 2012 Tianyin Pharmaceutical Co., Inc. 23rd Floor, Unionsun Yangkuo Plaza No. 2, Block 3, Renmin Road South Chengdu, P. R. China, 610041 Ladies and Gentlemen: In so acting, we have examined and relied upon the originals or] [Patrizio & Zhao, LLC Certified Public Accountants and Consultants 322 Route 46 West Parsippany, NJ 07054 Fax: (973) 882-0788 www.pzcpa.com Member of Alliance of worldwide accounting firms CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the use in the Post-Effective Amendment No. 3 to a Registration Statement on Form S-1 pertaining to the registration of 15,784,640 shares of]
WX [WuXi PharmaTech (Cayman)] 6-K: (Original Filing)
[WuXi PharmaTech (Cayman) Inc. Form 6-K Page 3 4]
